{
    "Trade/Device Name(s)": [
        "HemosIL Liquid Antithrombin"
    ],
    "Submitter Information": "Instrumentation Laboratory Company",
    "510(k) Number": "K062431",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033775"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JBQ"
    ],
    "Summary Letter Date": "August 18, 2006",
    "Summary Letter Received Date": "August 21, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7060"
    ],
    "Regulation Name(s)": [
        "Antithrombin III Assay"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Antithrombin"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrated tube"
    ],
    "Instrument(s)/Platform(s)": [
        "IL Coagulation Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Chromogenic assay"
    ],
    "Methodologies": [
        "Synthetic chromogenic substrate",
        "Factor Xa inactivation"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL Liquid Antithrombin automated chromogenic assay for Antithrombin quantitation in plasma",
    "Indications for Use Summary": "Automated chromogenic assay for quantitative determination of Antithrombin in human citrated plasma to aid in diagnosis of hereditary and acquired Antithrombin deficiency and to monitor Antithrombin substitution therapy",
    "fda_folder": "Hematology"
}